Search live federal opportunities

N66001-25-Q-6397- Notice of Intent to Award Sole Source to BIORAD LaboratoriesThe Department of the Navy, Naval Information Warfare Center Pacific (NIWC Pacific) hereby publicizes its intention to solicit, negotiate, and award a Commercial, Firm-Fixed-Price pu

Solicitation is attached.

SPE2D2-22-D-0150 P00007 to invoke Option Year 3 SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders. SPE2D2-22-D-0150 P00005 to invoke Option Year 2 SPE2D2-22-D-0150 P00003 to invoke Option Year 1 SPE2D2-22-D-0150 P00002 To incorporate Drug

Celecoxib Capsules Solicitation SPE2D2-25-R-0021.

Solicitation is attached.

2025-08-20 Modifications P00005 through P00008 added Modification P00004 SPE2D222D0145 to incorporate DCSA language into soliciation for subject contract. Modification P00003 SPE2D222D0145 to Invoke Option Year 1 for the period August 26, 2023 to August 25,

NATIONAL CONTRACT SPE2D223D0011 CLOBETASOL PROPIONATE 0.05% SOLUTION

Modification exercising of 3rd year option.

Sorafenib Tablets solicitation SPE2D2-25-R-0016

MODIFICATION SPE2D2-23-D-0010 P00005 SERVES TO ANNOUNCE THE EXERCISE OF THE SECOND-YEAR OPTION.

This is a Brand Name Only requirement; all qualified vendors are encouraged to submit a quote.Offerors shall submit a quote in response to the requirements of the United States Army Medical Research Acquisition Activity (USAMRAA) in support of the Office of th

Update 0001: Government response to RFIs have been added. Please access the solicitation module in PIEE to view the document.Notice to Offeror(s): Funds are presently available for this effort. The Government reserves the right to cancel this solicitation, eit

Modification SPE2D223D0009 P00002 posted to announce exercising of Option Year Two (2), effective July 25, 2025 through July 24, 2026.

Solicitation and amendments 001 and 002 attached.

SPE2D2-25-D-0014 Award

Sertraline HCL Tablets 25MG in 30, 90, 180 and 500 Count bottles, Sertraline HCL Tablets in 50MG in 30, 90, 180, and 500 Count bottles and Sertraline HCL Tablets in 30, 60, 90, 180 and 500 Count bottlles.

Modification to announce exercising 3rd option year.

Option Year 4 invoked for the period of June 08, 2025 through June 07, 2026. Solicitation SPE2D221R0104 Alendronate Sodium

SPE2D2-25-D-0012 Pramipexole Tablets Award

SPE2D2-25-D-0011 Olanzapine Tablets Award

FEBUXOSTAT - NATIONAL CONTRACT SPE2D2-22-D-0142

Amendment 0004 has been made to accomdate for solicitation changes pursuant to the authority of CD 2025-O0003 and CD 2025-O0004.

Solicitation attached.

AmerisourceBergen Drug Corp., Conshohocken, Pennsylvania, has been awarded an estimated $26,366,625,013.21 firm-fixed-price requirements contract under solicitation SPE2DX-24-R-0001 for pharmaceutical and pharmaceutical-related products. This was a competitive

DMS Pharmaceutical Group Inc., Park Ridge, Illinois, has been awarded an estimated $1,270,341,670.98 firm-fixed-price requirements contract under solicitation SPE2DX-24-R-0001 for pharmaceutical and pharmaceutical-related products. This was a competitive acqui